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Color Doppler ultrasonography imaging to guide transluminal most of their hospitalizations [1]; a proportion of patients
angioplasty of venous stenosis. receives an arteriovenous graft as an access for the deliv-
Background. The objective of access surveillance is the early ery of chronic hemodialysis. The progressive narrowingrecognition of dysfunction in order to be able to correct the
of the lumen of venous anastomosis or any more proxi-stenosis by angioplasty or surgery before access thrombosis
mal part of the venous circulation as a result of intimaloccurs. The advent of color Doppler imaging has enabled stud-
ies of color Doppler ultrasonography (CDU) for the guidance proliferation [2] is the main cause of graft failures. The
of percutaneous transluminal angioplasty (PTA). The aim of objective of access surveillance is the early recognition
the present study was to investigate whether color Doppler
of dysfunction in order to be able to correct the stenosisimaging alone can be safely and effectively used to diagnose
by angioplasty or surgery before access thrombosis oc-vascular graft access stenoses and guide subsequent PTA.
Methods. Using the ultrasound velocity dilution method, we curs. A number of studies support the assertion that
measured access blood flow (Qa) during the first hour of hemo- preventive intervention decreases access thrombosis,
dialysis every month in patients with grafts as vascular access. prolongs access life, and prevents inadequate dialysisWhen the decrease in Qa from the baseline value was 40% or
[3–7]. The latter point is of particular importance givenmore, CDU was performed and immediately followed by PTA
that a 7% decrease in mortality with every increase ofin the presence of a stenosis of more than 50%. The Qa was
then measured during the first dialysis after PTA and one 0.1 in the Kt/V index of dialysis adequacy at least until
month later. Repeated-measure analysis of variance was ap- 1.3 Kt/V [8]. Furthermore, preventive stenosis repair
plied to evaluate the early and late (after one month) effect
makes it possible to reduce the use of a catheter, decreaseof PTA.
the risk of infection and thrombosis, reduce the hospital-Results. Twelve PTAs were performed under CDU guid-
ance in nine patients and led to the elimination of the stenosis ization rates of patients with end-stage renal disease, and
or its reduction (two cases). The mean Qa was 809 6 263 mL/ diminish the cost of access management. Indeed, the
min at baseline, 468 6 153 before PTA, and 820 6 281 after Dialysis Outcomes Quality Initiative recommends a reg-PTA. The difference between the pre-PTA and post-PTA val-
ular program of access screening [9]. Ultrasonographyues was highly significant (P , 0.001), and the mean value
is a unique vascular access monitoring technique becauseafter PTA was not different from baseline (P 5 0.672). There
were no relevant complications directly related to the proce- of its ability to provide both anatomic (structural) and
dure. hemodynamic (functional) data. By means of this tech-
Conclusions. The CDU procedure is effective for the diag-
nique, it is thus possible to identify an access stenosisnosis of vascular access stenosis and as a guide during the PTA
and to quantitate the access flow [10]. The use of Dopplerprocedure. It could improve stenosis screening by avoiding the
risks of exposure to ionizing radiation and of adverse reactions ultrasonography allows the identification of a graft steno-
to contrast media. sis of more than 50%, with 92% sensitivity and 84%
specificity [11]. A new method of access screening is the
ultrasound dilution method for calculating access flowVascular access remains the Achilles heel of chronic
rate (Qa), a technique that is of value in identifyinghemodialysis patients, and its complications account for
the accesses at risk for thrombosis [12]. Percutaneous
transluminal angioplasty (PTA) is a well-established
Key words: thrombosis, hemodialysis, percutaneous transluminal angi-
therapeutic option for patients with vascular access ste-oplasty, chronic hemodialysis, arteriovenous graft, end-stage renal dis-
ease. nosis [6, 7]. It is conventionally guided and monitored
radiographically, but this carries the risks of ionizing
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guidance of lower limb arterial PTA [13–15]. The aim sensors (one on the arterial and one on the venous blood
line) [16], both of which were connected to a meter. Toof the present study was to investigate whether color
duplex imaging alone can be safely and effectively used measure access blood flow, the dialyzer blood lines were
reversed, and a temporary recirculation was created,to diagnose vascular graft access stenoses in hemodialytic
patients and guide PTA. after which 10 mL of isotonic saline were rapidly injected
into the venous line. Access blood flow was measured
using changes in ultrasound velocity through the blood
METHODS
lines as the blood concentration changes with respect to
Patients the actual dialyzer blood flow by means of the following
formula:Twenty-five of 235 patients (10.6%) had a vascular
graft access (mean age 68 6 10 years) by April 30, 1999.
Qac 5 Qb · (1/Kr 2 1)
In May 1999, we started using ultrasound velocity dilu-
tion to measure Qa in patients with vascular graft ac- where Qac is the access flow, Qb the dialyzer blood flow,
and Kr the recirculation coefficient; Kr is equal to Smix/cesses [16]. In the case of a decrease of Qa from the
baseline value of 40% or more, the vascular access was Sven, where Smix and Sven are the areas under the
dilution curves generated, respectively, by the arterialexamined using ultrasound color and spectral flow; if a
stenosis of more than 50% was detected [17], angioplasty and venous sensors. A more detailed explanation of the
method can be found elsewhere [16].was performed as an outpatient procedure during the
same session. The baseline value of Qa represents the
Angioplasty techniquefirst measurement in each graft after its placement or
the first measurement after exclusion of stenoses by a We performed PTA procedures in a radiology suite.
Under the control of CDU, a vascular sheath was in-CDU control. We chose a decrease of 40% or more in
Qa because, at this value, there is a strong increase in serted in the graft at a site along the loop that would
allow angioplasty to be performed. A guidewire wasthe relative risk for thromboses [18]. Two criteria were
to be satisfied to diagnose .50% stenoses by duplex passed through the vascular sheath until it reached the
stenosis and was then used to drive the angioplasty bal-scan: a lumen diameter reduction and a peak systolic
velocity ratio greater than 2. With this peak systolic ve- loon across the lesion. Before the angioplasty balloon
catheter was inserted, a heparin dose of 1,000 to 5,000 IUlocity ratio, a 50% or more reduction in lumen diameter
has been shown [19]. Twelve Doppler ultrasonography was usually administered in order to prevent thrombosis
during balloon inflation. The dilation of an intimal hyper-PTAs were performed in nine hemodialysis patients after
they had given their informed consent. plastic stenosis required the use of a high-pressure (.12
atm) angioplasty balloon (Blue Maxt; Boston Scientific,
Color-flow Doppler ultrasonography Boston, MA, USA) and a high-pressure inflation device
to expand the lesion fully [20, 21]. A 7 or 8 mm diameterThe vascular accesses were evaluated, and angioplasty
was performed using an ultrasound unit with color and balloon was typically used to dilate a 6 mm graft-vein
anastomosis. Immediately after the PTA procedure, wespectral flow Doppler capability (AU4 idea; ESAOTE
Biomedica, Genoa, Italy). The accesses were examined evaluated its adequacy by duplex scan with both a mor-
phologic and hemodynamic evaluation. We repeated theusing a 7.5 and 10 MHz transducer in the longitudinal
and transverse planes with or without color Doppler balloon dilation until the stenosis had disappeared on
color Doppler. In the case of an early recurrence offrom the feeding artery across the proximal arterial anas-
tomosis, through the entire graft, and into the distal vein stenosis, a stent (Easy Wallstent, Boston Science, Bos-
ton, MA, USA) was positioned, once again under theas far as the central venous system. A 50% reduction in
the luminal diameter of a blood vessel corresponded to control of CDU.
a 75% decrease in cross sectional area and was consid-
Statistical analysisered to represent a hemodynamically significant stenosis
[17]. The results are expressed as mean values 6 SD. The
evolution of Qa over time (baseline, before PTA, after
Access blood flow rate by ultrasound velocity dilution PTA, and one month later) was assessed by means of
repeated-measures analysis of variance using the generalThe direct baseline Qa of the vascular accesses was
determined by means of ultrasound velocity dilution linear model (GLM) procedure; the comparisons of in-
terest are those of each time point versus the previous(Transonic System Inc., Ithaca, NY, USA). The Qa was
also measured before every angioplasty procedure, after time point, and those of each time point versus baseline.
All of the statistical analyses were made using releaseevery angioplasty procedure (during the following hemo-
dialysis), and finally one month later. This previously 9.0 of SPSS for Windows statistical software. A P value
of less than 0.05 was considered statistically significant.described and validated technique used two reusable clip
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Table 1. Patient characteristics increases the expenses necessary for end-stage renal dis-
ease patients on chronic maintenance hemodialysis ther-Patient number 9
Sex M/F 6/3 apy [22]. The endogenous arteriovenous fistula remains
Age years 77 (51–84) the first choice of dialysis access, but vascular grafts areTime on dialysis months 41 (5–242)
used in patients with impaired distal and proximal fistu-Access location in all the patients Lower arm
Graft type las. Most grafts fail because of the development of neoin-
Mesenteric bovine vein 5 timal hyperplasia at the distal venous anastomosis [3].Expanded-PTFE 4
To provide adequate dialysis therapy on a continuingGraft configuation
Loop 8 basis and to ensure the longevity of the vascular access,
Straight 1 such stenotic lesions need to be diagnosed early and
Statistics are counts or medians (range). effectively treated [23]. Increased access survival has
been associated with surveillance programs, and like
Schwab et al, we believe that a venous stenosis should
be corrected whenever it is detected [3, 24]. In compari-RESULTS
son with surgical revision, PTA has the advantages thatThe characteristics of the patient population are
it is a shorter procedure, causes less stress to patients,shown in Table 1. All of the grafts with a 40% or more
obviates the need for hospitalization, enables immediatedecrease in Qa from the baseline value had a .50%
dialysis without the need for a central venous catheter,stenosis as detected by duplex scan. Twelve angioplasty
reduces the risk of infection, and saves the patient’s veinprocedures under the control of color-flow Doppler ul-
[25]. In patients with vascular graft accesses, 93% of thetrasonography were performed in nine patients (Table
stenotic lesions are located between the arterial anasto-1). The stenoses were located six times at the site of
mosis and axillary vein [26], and the rationale for per-venous anastomosis, the other six times at the venous
forming ultrasonographically guided PTA is the locationsite, less than 3 cm from the venous anastomosis. All of
of the stenoses and the high degree of sensitivity andthe vascular accesses were patent four weeks after PTA,
specificity of Doppler ultrasonography in detecting themwith a Qa of 754 6 242 mL/min. In two patients, we
[11]. Our data suggest that duplex-guided PTA is bothfound a restenosis at the same point (venous anastomosis
feasible and effective, as shown by improvement in Qaand less than 1 cm far from the venous anastomosis)
measured using the ultrasound velocity dilution tech-after one month, and an Easy Wallstent was positioned
nique. However, the fact that the Qa measured oneusing the same procedure: one into the vein upon venous
month later was less than that reached after PTA (P ,anastomosis and the other into the venous anastomosis
0.006) suggests that the behavior of Qa should be moni-in the elbow (flexion point). No significant complications
tored during follow-up in order to ascertain if and whendirectly related to the procedure occurred during any of
another PTA is necessary.the PTAs, and radiographic imaging was never required.
Duplex-guided PTA is not only effective in preventingFrom the morphological point of view, all of the proce-
vascular access stenosis, but also improves access surveil-dures led to the elimination of the stenosis or to its
lance because it avoids the use of x-ray contrast materialreduction (,30% residual narrowing in two cases).
(and its potential allergic reaction) and patient exposureTo evaluate the efficacy of the PTA procedure, Qa
to radiation. It is also less expensive and, in our experi-was measured at baseline, before and after PTA, and
ence, easily and rapidly performed by nephrologists.one month later (Table 2). The mean Qa values were
However, the most significant advantage of duplex-809 6 263 mL/min at baseline, 468 6 153 before and
guided PTA is the possibility of correcting the anatomi-820 6 281 after PTA; the difference between the pre-
cal and the hemodynamic abnormality because, after thePTA and post-PTA values was highly significant (P ,
procedure, we reached the same access blood flow as0.001), and the mean value after PTA was not different
that observed during the period of surveillance. Thefrom baseline (P 5 0.672). However, one month after
method is already used for lower limb arterial lesionsPTA, Qa decreased to 754 6 242 mL/min (P , 0.006).
[15], with an indication to treat approximately 60% ofWe also evaluated the cost of PTA procedures with the
all claudicants with stenotic disease. Given the positionDoppler ultrasonography and angiography approaches
of vascular accesses on the forearm or arm, we found(Table 3). The higher cost (15%) of angiography was
that duplex ultrasonography allowed the treatment ofmainly because of the contrast material and the mainte-
100% of the stenotic lesions. The present challenge fac-nance and amortization of a more expensive device.
ing the nephrology and radiology communities is to es-
tablish and implement the screening and operative pro-
DISCUSSION cedures that best achieve the goals of detecting a stenosis
before the onset of thrombosis and decreasing the accessA malfunctioning permanent vascular access remains
a leading cause of morbidity and possible mortality, and thrombosis rate in a way that is effective for grafts and
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Table 2. Access blood flow rate (Qa) at baseline, before, and after color flow Doppler ultrasonography PTA, and one month later
Qa mL/min
Baseline Before PTA After PTA After one month from PTA
N 12 12 12 12
Minimum 490 260 395 400
Maximum 1235 720 1245 1180
Mean 809 468 820 754
Standard deviation 263 153 281 242
P value versus mean baseline valuea 0.001 0.672 0.041
P value versus previous mean valuea 0.001 0.001 0.006
a From the repeated-measures analysis of variance by the general linear model procedure
Table 3. Cost analysis of one PTA procedure with the two Doppler National Kidney Foundation Dialysis Outcomes Quality Ini-
tiative. Am J Kidney Dis 30(Suppl):S150–S191, 1997Ultrasonography and Angiography approaches.
Values expressed in US dollars. 10. Sullivan KL, Goldman JM: Screening and justification for pro-
phylactic intervention in failing hemodialysis grafts and fistulae.
Doppler ultrasonography Angiography Semin Dial 11:347–350, 1998
11. Tordoir JHM, de Bruin HG, Hoeneveld H, Eikelboom BC, Kit-Equipment for PTA 1110 1110
slaar PJ: Duplex ultrasound scanning in the assessment of arterio-Contrast agent 0 90
venous fistulas created for hemodialysis access: Comparison withTwo medical doctorsa 63.6 63.6
digital subtraction angiography. J Vasc Surg 10:122–128, 1989Techniciana 0 16.5
12. May RE, Himmelfarb J, Yenicesu M, Knights S, Ikizler TA,Nursea 16.5 16.5
Shulman G, Hernanz-Schulman M, Shyr Y, Hakim MR: Pre-Maintenance 0.3 28
dictive measures of vascular access thrombosis: A prospectiveAmortization 0.8 38
study. Kidney Int 52:1656–1662, 1997Total 1191.2 1362.6
13. Cluley SR, Brener BJ, Hollier L, Schoenfeld R, Novick A,
a Both procedures took about one hour. Vilkomerson D: Transcutaneous ultrasonography can be used to
guide and monitor balloon angioplasty. J Vasc Surg 17:23–31, 1993
14. Ramaswami G, al-Kutoubi A, Nicolaides AN, Geroulakos G,
Ferrara-Ryan M, Aref F: Duplex controlled angioplasty. Eur Jfistulae and easily and rapidly performed by dialysis staff Vasc Surg 8:457–463, 1994
[27]. Our procedure seems to be capable of achieving 15. London NJM, Nydahl S, Hartshorne T, Fishwick G: Use of
colour duplex imaging to diagnose and guide angioplasty of lowerthis and may thus reduce the morbidity and mortality of
limb arterial lesions. Br J Surg 86:911–915, 1999dialysis patients in a cost-effective manner. 16. Krivitski NM: Theory and validation of access flow measurement
by dilution technique during hemodialysis. Kidney Int 48:244–250,
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